Procalcitonin to guide duration of antibiotic therapy in intensive care patients: A randomised prospective controlled trial

Abstract

In surgical intensive care patients, monitoring of procalcitonin (PCT) is a helpful tool for guiding antibiotic treatment when compared with a standard eight day regimen. This may contribute to an optimised antibiotic regimen with beneficial effects on microbial resistance and costs in intensive care medicine.